1. Home
  2. INGN vs CBUS Comparison

INGN vs CBUS Comparison

Compare INGN & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

SELL

Current Price

$5.77

Market Cap

136.1M

Sector

Health Care

ML Signal

SELL

Logo Cibus Inc.

CBUS

Cibus Inc.

BUY

Current Price

$1.59

Market Cap

116.2M

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
INGN
CBUS
Founded
2001
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.1M
116.2M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
INGN
CBUS
Price
$5.77
$1.59
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$12.00
★ $14.33
AVG Volume (30 Days)
★ 377.8K
107.2K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
★ 74.33
EPS
★ N/A
N/A
Revenue
★ $348,668,000.00
$3,639,000.00
Revenue This Year
$2.22
$42.75
Revenue Next Year
$4.55
$139.28
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.86
N/A
52 Week Low
$5.05
$1.09
52 Week High
$9.13
$4.19

Technical Indicators

Market Signals
Indicator
INGN
CBUS
Relative Strength Index (RSI) 59.20 49.08
Support Level $5.48 $1.48
Resistance Level $6.73 $1.62
Average True Range (ATR) 0.21 0.12
MACD 0.11 0.02
Stochastic Oscillator 66.67 57.14

Price Performance

Historical Comparison
INGN
CBUS

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: